Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
Q.4 (Alpha)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Q.4 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.4 (Alpha)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
Q.4 (Alpha)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Q.4 (Alpha)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Q.4 (Alpha)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Q.4 (Alpha)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Q.4 (Alpha)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-17195.6Germany
BE.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BE.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BE.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BE.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.9.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.9.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.9.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.9.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.9.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.9.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.9.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.6.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.6.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.6.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.6.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.6.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.6.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.6.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.6.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.34EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.34ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.34ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.34EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.34EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.34ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.12ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
CH.1.1.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-20199.5Germany
CH.1.1.12EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CH.1.1.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-20212.4China
CH.1.1.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.37EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used